As parents and students gear up to go back to school next month, there is uncertainty about whether public schools will be able to require vaccines against COVID-19.
Meanwhile, local researchers are entering phase two of clinical trials on the Pfizer vaccine for children under 12, and those trials could be an important part of that puzzle.
Joining Cincinnati Edition to talk about the vaccine trials and how COVID-19 has been impacting young people locally are Cincinnati Children's Hospital Vaccine Research Center Director Dr. Robert Frenck and Cincinnati Children's Hospital Associate Division Director for Primary Care Mary Carol Burkhardt.
Listen to Cincinnati Edition live at noon M-F. Audio for this segment will be uploaded after 4 p.m. ET.
Never miss an episode by subscribing to our podcast: